|
1
|
Kessler RC, Berglund P, Demler O, et al:
The epidemiology of major depressive disorder: results from the
National Comorbidity Survey Replication (NCS-R). JAMA.
289:3095–3105. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nemeroff CB: The burden of severe
depression: a review of diagnostic challenges and treatment
alternatives. J Psychiatr Res. 41:189–206. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rosen RC and Marin H: Prevalence of
antidepressant-associated erectile dysfunction. J Clin Psychiatry.
64(Suppl 10): 5–10. 2003.
|
|
4
|
Evans CG, Chang L and Gestwicki JE: Heat
shock protein 70 (hsp70) as an emerging drug target. J Med Chem.
53:4585–4602. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parsell DA and Lindquist S: The function
of heat-shock proteins in stress tolerance: degradation and
reactivation of damaged proteins. Annu Rev Genet. 27:437–496. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sharp FR, Massa SM and Swanson RA:
Heat-shock protein protection. Trends Neurosci. 22:97–99. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ooie T, Takahashi N, Saikawa T, et al:
Single oral dose of geranylgeranylacetone induces heat-shock
protein 72 and renders protection against ischemia/reperfusion
injury in rat heart. Circulation. 104:1837–1843. 2001. View Article : Google Scholar
|
|
8
|
Guo S, Wharton W, Moseley P and Shi H:
Heat shock protein 70 regulates cellular redox status by modulating
glutathione-related enzyme activities. Cell Stress Chaperones.
12:245–254. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kimmins S and MacRae TH: Maturation of
steroid receptors: an example of functional cooperation among
molecular chaperones and their associated proteins. Cell Stress
Chaperones. 5:76–86. 2000. View Article : Google Scholar
|
|
10
|
Rajapandi T, Greene LE and Eisenberg E:
The molecular chaperones Hsp90 and Hsc70 are both necessary and
sufficient to activate hormone binding by glucocorticoid receptor.
J Biol Chem. 275:22597–22604. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shimizu S, Nomura K, Ujihara M, et al: An
allel-specific abnormal transcript of the heat shock protein 70
gene in patients with major depression. Biochem Biophys Res Commun.
219:745–752. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martini F, Fernández C, Segundo LS,
Tarazona JV and Pablos MV: Assessment of potential immunotoxic
effects caused by cypermethrin, fluoxetine, and thiabendazole using
heat shock protein 70 and interleukin-1beta mRNA expression in the
anuran Xenopus laevis. Environ Toxicol Chem. 29:2536–2543.
2010. View
Article : Google Scholar
|
|
13
|
Yu J, Roh S, Lee JS, et al: The effects of
venlafaxine and dexamethasone on the expression of HSP70 in rat C6
glioma cells. Psychiatry Investig. 7:43–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Allagui MS, Nciri R, Rouhaud MF, et al:
Long-term exposure to low lithium concentrations stimulates
proliferation, modifies stress protein expression pattern and
enhances resistance to oxidative stress in SH-SY5Y cells. Neurochem
Res. 34:453–462. 2009. View Article : Google Scholar
|
|
15
|
Hirakawa T, Rokutan K, Nikawa T and Kishi
K: Geranylgeranylacetone induces heat shock proteins in cultured
guinea pig gastric mucosal cells and rat gastric mucosa.
Gastroenterology. 111:345–357. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ishii Y, Kwong JM and Caprioli J: Retinal
ganglion cell protection with geranylgeranylacetone, a heat shock
protein inducer, in a rat glaucoma model. Invest Ophthalmol Vis
Sci. 44:1982–1992. 2003. View Article : Google Scholar
|
|
17
|
Latchman DS: Heat shock proteins and
cardiac protection. Cardiovasc Res. 51:637–646. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamagami K, Yamamoto Y, Ishikawa Y,
Yonezawa K, Toyokuni S and Yamaoka Y: Effects of
geranyl-geranyl-acetone administration before heat shock
preconditioning for conferring tolerance against
ischemia-reperfusion injury in rat livers. J Lab Clin Med.
135:465–475. 2000. View Article : Google Scholar
|
|
19
|
Katsuno M, Sang C, Adachi H, et al:
Pharmacological induction of heat-shock proteins alleviates
polyglutamine-mediated motor neuron disease. Proc Natl Acad Sci
USA. 102:16801–16806. 2005. View Article : Google Scholar
|
|
20
|
Tanito M, Kwon YW, Kondo N, et al:
Cytoprotective effects of geranylgeranylacetone against retinal
photooxidative damage. J Neurosci. 25:2396–2404. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yasuda H, Shichinohe H, Kuroda S, Ishikawa
T and Iwasaki Y: Neuroprotective effect of a heat shock protein
inducer, geranylgeranylacetone in permanent focal cerebral
ischemia. Brain Res. 1032:176–182. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo FC, Qi L, Lv T, et al:
Geranylgeranylacetone protects mice against morphine-induced
hyperlocomotion, rewarding effect, and withdrawal syndrome. Free
Radic Biol Med. 52:1218–1227. 2012. View Article : Google Scholar
|
|
23
|
Meyer JH, Ginovart N, Boovariwala A, et
al: Elevated monoamine oxidase a levels in the brain: an
explanation for the monoamine imbalance of major depression. Arch
Gen Psychiatry. 63:1209–1216. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Duman RS: Depression: a case of neuronal
life and death? Biol Psychiatry. 56:140–145. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Manji HK, Drevets WC and Charney DS: The
cellular neurobiology of depression. Nat Med. 7:541–547. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mathew SJ, Manji HK and Charney DS: Novel
drugs and therapeutic targets for severe mood disorders.
Neuropsychopharmacology. 33:2080–2092. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Elhwuegi AS: Central monoamines and their
role in major depression. Prog Neuropsychopharmacol Biol
Psychiatry. 28:435–451. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Du L, Faludi G, Palkovits M, Sotonyi P,
Bakish D and Hrdina PD: High activity-related allele of MAO-A gene
associated with depressed suicide in males. Neuroreport.
13:1195–1198. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wouters J: Structural aspects of monoamine
oxidase and its reversible inhibition. Curr Med Chem. 5:137–162.
1998.PubMed/NCBI
|
|
30
|
Riederer P, Lachenmayer L and Laux G:
Clinical applications of MAO-inhibitors. Curr Med Chem.
11:2033–2043. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Terano A, Shiga J, Hiraishi H, Ota S and
Sugimoto T: Protective action of tetraprenylacetone against
ethanol-induced damage in rat gastric mucosa. Digestion.
35:182–188. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hirota K, Nakamura H, Arai T, et al:
Geranylgeranylacetone enhances expression of thioredoxin and
suppresses ethanol-induced cytotoxicity in cultured hepatocytes.
Biochem Biophys Res Commun. 275:825–830. 2000. View Article : Google Scholar
|
|
33
|
Bremner JD: Does stress damage the brain?
Biol Psychiatry. 45:797–805. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bremner JD, Narayan M, Anderson ER, Staib
LH, Miller HL and Charney DS: Hippocampal volume reduction in major
depression. Am J Psychiatry. 157:115–118. 2000.
|
|
35
|
Colla M, Kronenberg G, Deuschle M, et al:
Hippocampal volume reduction and HPA-system activity in major
depression. J Psychiatr Res. 41:553–560. 2007.PubMed/NCBI
|
|
36
|
Eastwood SL and Harrison PJ: Synaptic
pathology in the anterior cingulate cortex in schizophrenia and
mood disorders. A review and a western blot study of synaptophysin,
GAP-43 and the complexins. Brain Res Bull. 55:569–578. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lenze E, Cross D, McKeel D, Neuman RJ and
Sheline YI: White matter hyperintensities and gray matter lesions
in physically healthy depressed subjects. Am J Psychiatry.
156:1602–1607. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nolan CL, Moore GJ, Madden R, et al:
Prefrontal cortical volume in childhood-onset major depression:
preliminary findings. Arch Gen Psychiatry. 59:173–179.
2002.PubMed/NCBI
|
|
39
|
Ongür D, Drevets WC and Price JL: Glial
reduction in the subgenual prefrontal cortex in mood disorders.
Proc Natl Acad Sci USA. 95:13290–13295. 1998.PubMed/NCBI
|
|
40
|
Bachis A, Cruz MI, Nosheny RL and
Mocchetti I: Chronic unpredictable stress promotes neuronal
apoptosis in the cerebral cortex. Neurosci Lett. 442:104–108. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gould E and Tanapat P: Stress and
hippocampal neurogenesis. Biol Psychiatry. 46:1472–1479. 1999.
View Article : Google Scholar
|
|
42
|
McEwen BS: Physiology and neurobiology of
stress and adaptation: central role of the brain. Physiol Rev.
87:873–904. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lee AL, Ogle WO and Sapolsky RM: Stress
and depression: possible links to neuron death in the hippocampus.
Bipolar Disord. 4:117–128. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Woo M, Hakem R, Soengas MS, et al:
Essential contribution of caspase 3/CPP32 to apoptosis and its
associated nuclear changes. Genes Dev. 12:806–819. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Salvesen GS: Caspases: opening the boxes
and interpreting the arrows. Cell Death Differ. 9:3–5. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ghavami S, Hashemi M, Ande SR, et al:
Apoptosis and cancer: mutations within caspase genes. J Med Genet.
46:497–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ghribi O, Herman MM and Savory J: The
endoplasmic reticulum is the main site for caspase-3 activation
following aluminum-induced neurotoxicity in rabbit hippocampus.
Neurosci Lett. 324:217–221. 2002. View Article : Google Scholar
|
|
48
|
Shiraishi H, Okamoto H, Yoshimura A and
Yoshida H: ER stress-induced apoptosis and caspase-12 activation
occurs downstream of mitochondrial apoptosis involving Apaf-1. J
Cell Sci. 119:3958–3966. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kim YH, Song JJ, Kim YC, et al:
Geranylgeranylacetone ameliorates acute cochlear damage caused by
3-nitropropionic acid. Neurotoxicology. 31:317–325. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mikuriya T, Sugahara K, Sugimoto K, et al:
Attenuation of progressive hearing loss in a model of age-related
hearing loss by a heat shock protein inducer,
geranylgeranylacetone. Brain Res. 1212:9–17. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fujiki M, Kobayashi H, Abe T and Ishii K:
Astroglial activation accompanies heat shock protein upregulation
in rat brain following single oral dose of geranylgeranylacetone.
Brain Res. 991:254–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mosser DD, Caron AW, Bourget L, et al: The
chaperone function of hsp70 is required for protection against
stress-induced apoptosis. Mol Cell Biol. 20:7146–7159. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yin HY, Ma XF, Liu F, Xia M and Xu AT:
Protective effect of geranylgeranylacetone on cisplatin
ototoxicity. Chemotherapy. 55:1–5. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li CY, Lee JS, Ko YG, Kim JI and Seo JS:
Heat shock protein 70 inhibits apoptosis downstream of cytochrome c
release and upstream of caspase-3 activation. J Biol Chem.
275:25665–25671. 2000. View Article : Google Scholar : PubMed/NCBI
|
